All Stories

  1. Reduced Microvascular Density in Omental Biopsies of Children with Chronic Kidney Disease
  2. Cardiovascular Phenotypes in Children with CKD: The 4C Study
  3. Kidney transplantation fails to provide adequate growth in children with chronic kidney disease born small for gestational age
  4. Wnt signaling contributes to vascular calcification by induction of matrix metalloproteinases
  5. Vitamin D status in children with chronic kidney disease
  6. Carbamylation des protéines plasmatiques chez l’enfant en insuffisance rénale chronique
  7. Quantitative Histomorphometry of the Healthy Peritoneum
  8. Protective effects of the polyphenols (+)-episesamin and sesamin against PDGF-BB-induced activation of vascular smooth muscle cells are mediated by induction of haem oxygenase-1 and inhibition of mitogenic signalling
  9. Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium
  10. The matrix metalloproteinases 2 and 9 initiate uraemic vascular calcifications
  11. Kardiovaskuläre Morbidität bei Kindern und Jugendlichen mit chronischer Nierenerkrankung
  12. Refractory arterial hypertension and renal failure combined with cerebral seizures and pancytopenia in a 5-year-old girl with bilateral nephromegaly: Answers
  13. Refractory arterial hypertension and renal failure combined with cerebral seizures and pancytopenia in a 5-year-old girl with bilateral nephromegaly: Questions
  14. 1D.06
  15. Aortic Pulse Wave Velocity in Healthy Children and Adolescents: Reference Values for the Vicorder Device and Modifying Factors
  16. Clinical and Molecular Characterization of Patients with Heterozygous Mutations in Wilms Tumor Suppressor Gene 1
  17. Markers of Bone Metabolism Are Affected by Renal Function and Growth Hormone Therapy in Children with Chronic Kidney Disease
  18. Is peritoneal dialysis still an equal option? Results of the Berlin pediatric nocturnal dialysis program
  19. ALindera obtusilobaExtract Blocks Calcium-/Phosphate-Induced Transdifferentiation and Calcification of Vascular Smooth Muscle Cells and Interferes with Matrix Metalloproteinase-2 and Metalloproteinase-9 and NF-κB
  20. Patterns of Growth after Kidney Transplantation among Children with ESRD
  21. The lignan (+)-episesamin interferes with TNF-α-induced activation of VSMC via diminished activation of NF-ĸB, ERK1/2 and AKT and decreased activity of gelatinases
  22. Serum suPAR levels are modulated by immunosuppressive therapy of minimal change nephrotic syndrome
  23. Pädiatrische Nephrologie
  24. Inhibition of vascular calcification by block of intermediate conductance calcium-activated potassium channels with TRAM-34
  25. CTLA4 Polymorphisms in Minimal Change Nephrotic Syndrome in Children: A Case-Control Study
  26. Response to Intima-Media Thickness in Children--Need for More Parameters
  27. Hemodiafiltration in a pediatric nocturnal dialysis program
  28. Knochenstoffwechsel bei chronischer Niereninsuffizienz im Kindesalter
  29. Unknown pathomechanisms of renal impairment in PKU
  30. Birth parameters and parental height predict growth outcome in children with chronic kidney disease
  31. Vitamin D in early life: good or bad for food allergies?
  32. Carotid Artery Intima-Media Thickness and Distensibility in Children and Adolescents: Reference Values and Role of Body Dimensions
  33. Mycophenolate Mofetil versus Cyclosporin A in Children with Frequently Relapsing Nephrotic Syndrome
  34. Growth and maturation improvement in children on renal replacement therapy over the past 20 years
  35. Paediatric nephrology II
  36. Paediatric nephrology - A
  37. Peritoneal dialysis - A
  38. Modeling of Oxidized PTH (oxPTH) and Non-oxidized PTH (n-oxPTH) Receptor Binding and Relationship of Oxidized to Non-Oxidized PTH in Children with Chronic Renal Failure, Adult Patients on Hemodialysis and Kidney Transplant Recipients
  39. Vitamin D and inflammation
  40. Chronic kidney disease in adolescent and adult patients with phenylketonuria
  41. Submaximal suppression of parathyroid hormone ameliorates calcitriol-induced aortic calcification and remodeling and myocardial fibrosis in uremic rats
  42. Restoration of Bone Mineralization by Cinacalcet is Associated with a Significant Reduction in Calcitriol-Induced Vascular Calcification in Uremic Rats
  43. Pediatrics: When should children surviving a Wilms tumor be transplanted?
  44. Restoration of bone mineralization by cinacalcet or parathyroidectomy is associated with a significant reduction in calcitriol-induced vascular calcification in uremic rats
  45. Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies
  46. Migration background and patient satisfaction in a pediatric nephrology outpatient clinic
  47. Validating a New Oscillometric Device for Aortic Pulse Wave Velocity Measurements in Children and Adolescents
  48. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome
  49. Laudatio für Herrn Universitätsprofessor Dr. med. Dirk Erhard Müller-Wiefel anlässlich seines Ausscheidens in den Ruhestand, Hamburg den 30.4.2010
  50. Significance of Molecular Testing for Congenital Chloride Diarrhea
  51. Continuous veno-venous single-pass albumin hemodiafiltration in children with acute liver failure*
  52. CNNM2, Encoding a Basolateral Protein Required for Renal Mg2+ Handling, Is Mutated in Dominant Hypomagnesemia
  53. Kardiovaskuläre Komorbidität bei Kindern mit chronischer Niereninsuffizienz: erste Ergebnisse der 4C-Studie
  54. Unterscheiden sich Kinder und Jugendliche mit angeborener, hereditärer oder erworbener chronischer Niereninsuffizienz im Wachstum?
  55. Die Notwendigkeit der Wachstumshormontherapie bei Kindern mit chronischer Nierenerkrankung in Abhängigkeit von Geburtsdaten und Elterngröße
  56. The podocyte as a target: cyclosporin A in the management of the nephrotic syndrome caused by WT1 mutations
  57. 1,25-Dihydroxyvitamin D3-induced aortic calcifications in experimental uremia: up-regulation of osteoblast markers, calcium-transporting proteins and osterix
  58. Hyperlipidämie
  59. Oligurie, Anurie und Nierenversagen
  60. A Hospital-Based Intermittent Nocturnal Hemodialysis Program for Children and Adolescents
  61. Vitamin A metabolism is changed in donors after living-kidney transplantation: an observational study
  62. Autorinnen und Autoren
  63. Langzeitprobleme pädiatrischer Patienten nach dem Transfer in die Erwachsenennephrologie
  64. Age-related stature and linear body segments in children with X-linked hypophosphatemic rickets
  65. Intensivierte Dialyseverfahren im Kindes- und Jugendalter
  66. Hypochloremic metabolic alkalosis and failure to thrive: answer
  67. Hypochloremic metabolic alkalosis and failure to thrive: question
  68. Polyoma virus-associated progressive multifocal leukoencephalopathy after renal transplantation: Regression following withdrawal of mycophenolate mofetil
  69. The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) Study: Objectives, Design, and Methodology
  70. Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window
  71. Severe complications after endoscopic injection of polydimethylsiloxane for the treatment of vesicoureteral reflux in early childhood
  72. Prematurity, small for gestational age and perinatal parameters in children with congenital, hereditary and acquired chronic kidney disease
  73. Decreased Transplant Arteriosclerosis in Endothelial Nitric Oxide Synthase-Deficient Mice
  74. Successful treatment of steroid-resistant nephrotic syndrome associated with WT1 mutations
  75. Targeted deletion of murine Cldn16 identifies extra- and intrarenal compensatory mechanisms of Ca2+ and Mg2+ wasting
  76. Urämische Vaskulopathie im Kindesalter
  77. Vital bedrohliche Dehydratation: neonatale Manifestation eines Bartter- Syndroms (BS)
  78. Activation of the AKT/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD)
  79. Magnetic Resonance Imaging of Iron Overload in Children Treated with Peritoneal Dialysis
  80. Therapie der arteriellen Hypertonie im Kindes- und Jugendalter
  81. Efficacy and Safety of Basiliximab in Pediatric Renal Transplant Patients Receiving Cyclosporine, Mycophenolate Mofetil, and Steroids
  82. Oxidative stress markers in young hemodialysis patients – a pilot study
  83. Magnesium stimulates renal phosphate reabsorption
  84. The clinical course of steroid-sensitive childhood nephrotic syndrome is associated with a functional IL12B promoter polymorphism
  85. Arterial stiffness in children after renal transplantation
  86. Intensified hemodialysis regimens: neglected treatment options for children and adolescents
  87. Cardiovascular Disease in Pediatric Chronic Kidney Disease
  88. Contributors
  89. Atherogenesis-Is It Accelerated in Uremia?
  90. Polycythemia and increased erythropoietin in a patient with chronic kidney disease
  91. A cutaneous disease with multisystem involvement: hypomelanosis of Ito may be associated with proteinuria, focal segmental glomerulosclerosis and end-stage renal disease
  92. Uremia-related vascular calcification: More than apatite deposition
  93. Intrarenal Abscesses Due to Ureaplasma urealyticum in a Transplanted Kidney
  94. Reply
  95. Severe parvovirus B19 encephalitis after renal transplantation
  96. Growth impairment shows an age-dependent pattern in boys with chronic kidney disease
  97. A complex phenotype with cystic renal disease
  98. Thoracic versus whole body bioimpedance measurements: the relation to hydration status and hypertension in peritoneal dialysis patients
  99. A Randomized Crossover Trial Comparing Sevelamer With Calcium Acetate in Children With CKD
  100. Treatment of severe renal artery stenosis by percutaneous transluminal renal angioplasty and stent implantation
  101. Refeeding oedema
  102. Nierentransplantation im Kindes- und Jugendalter
  103. Tu-P7: 150 Impact of vitamin D therapy on arterial and cardiac disease in young adults with renal disease
  104. A novel WT1 missense mutation presenting with Denys-Drash syndrome and cortical atrophy
  105. DESMOPRESSIN ASSOCIATED SYMPTOMATIC HYPONATREMIC HYPERVOLEMIA IN CHILDREN. ARE THERE PREDICTIVE FACTORS?
  106. Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2D3
  107. Severe atherosclerosis of the aorta and development of peripheral T-cell lymphoma in an adolescent with angiolymphoid hyperplasia with eosinophilia
  108. Isolated sarcoid granulomatous interstitial nephritis responding to infliximab therapy
  109. The therapeutic potential of novel phosphate binders
  110. Hyperlipidämie
  111. Oligurie, Anurie und Nierenversagen
  112. The effect of sevelamer on the pharmacokinetics of cyclosporin A and mycophenolate mofetil after renal transplantation
  113. Effect of renal transplantation in childhood on longitudinal growth and adult height
  114. The clinical significance of vascular calcification in young patients with end-stage renal disease
  115. NPHS2 mutation associated with recurrence of proteinuria after transplantation
  116. Post-transplantation swelling of the lower eyelid
  117. Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil
  118. Cardiovascular considerations of pediatric ESRD
  119. Pediatric renal transplantation with mycophenolate mofetil-based immunosuppression without induction: results after three years1,2
  120. Prevalence of arterial hypertension and its morbidity in children and adolescents 3 years after renal transplantation with mycophenolate mofetil-based immunosuppression
  121. Encephalopathy and exposure to Shiga toxin without evidence of haemolytic uraemic syndrome
  122. Is atherosclerosis accelerated in young patients with end-stage renal disease? The contribution of paediatric nephrology
  123. Type I IgE receptor, interleukin 4 receptor and interleukin 13 polymorphisms in children with nephrotic syndrome
  124. Type I IgE receptor, interleukin 4 receptor and interleukin 13 polymorphisms in children with nephrotic syndrome
  125. Posttransplant lymphoproliferative disease in a child: clinical and molecular characterization
  126. Analysis of Cognitive and Motor Functioning during Pubertal Development: A New Approach.
  127. A stepwise approach to the treatment of early onset nephrotic syndrome
  128. Lipoprotein(a) inhibits proliferation of human umbilical venous endothelial cells (HUVEC) in vitro
  129. Analysis of muscle strength and bone structure in children with renal disease
  130. Verbesserung der Nierenfunktion nach langjähriger präterminaler Niereninsuffizienz bei infravesikaler Obstruktion
  131. Clinical outcome of Schönlein-Henoch purpura nephritis in children
  132. Intravenous iron treatment of renal anemia in children on hemodialysis
  133. Long-Term Treatment with Growth Hormone has no Persisting Effect on Lipoprotein (a) in Patients with Turnerʼs Syndrome
  134. MR cholangiography in children with autosomal recessive polycystic kidney disease
  135. Disseminated cutaneous plasmacellular granuloma associated with membranous glomerulonephritis
  136. Long-Term Treatment with Growth Hormone Has No Persisting Effect on Lipoprotein(a) in Patients with Turner's Syndrome
  137. Long-Term Treatment with Growth Hormone Has No Persisting Effect on Lipoprotein(a) in Patients with Turner’s Syndrome
  138. Should hyperlipidemia in children with the nephrotic syndrome be treated?
  139. Probucol for treatment of hyperlipidemia in persistent childhood nephrotic syndrome
  140. PROGRESSIVE SUBRETINAL FIBROSIS IN A CHILD FOLLOWING HEMOLYTIC UREMIC SYNDROME
  141. Levamisole treatment in steroid-sensitive and steroid-resistant nephrotic syndrome
  142. Lack of large, homozygous deletions of the nephronophthisis 1 region in Joubert syndrome type B
  143. 2.P.243 Self-reported physical activity in healthy children is correlated with cardiovascular risk factors
  144. 1.P.50 Vitamin D and parathormone have antagonistic effects on lipoprotein lipase in adipocytes
  145. Cerebral complications in Schimke immuno-osseous dysplasia
  146. Vomiting, headache and seizures in a child with idiopathic nephrotic syndrome
  147. Medical and psychosocial rehabilitation of young adults receiving renal replacement therapy since childhood: a single-centre experience
  148. Immune Response to the 23-Valent Pneumococcal Polysaccharide Vaccine in Lymphoma Patients and Patients with Chronic Renal Diseases
  149. Aplasia of the cerebellar vermis associated with chronic renal disease
  150. Treatment with growth hormone increases lipoprotein(a) serum levels in children with chronic renal insufficiency
  151. Treatment with growth hormone increases lipoprotein(a) serum levels in children with chronic renal insufficiency
  152. Case of the month
  153. Pneumococcal vaccine in children and young adults with chronic renal disease
  154. Ultrasound findings in juvenile nephronophthisis
  155. Diagnosis and treatment of a child with the syndrome of apparent mineralocorticoid excess type 1
  156. Acute glaucoma and intracranial hypertension in a child on long-term peritoneal dialysis treated with growth hormone
  157. Differential effects of gamma-interferon on the uptake of native and oxidized lipoproteins by human macrophages in vitro
  158. Renale tubul�re Dysgenesie mit fetaler Nierenvenenthrombose
  159. Hyperlipoproteinämie und Lipidperoxidation bei chronischen Nierenerkrankungen
  160. Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease
  161. Ask the expert
  162. Disturbances of lipid metabolism in children with chronic renal failure
  163. Lipoprotein(a) Serum Levels and Apolipoprotein(a) Phenotypes in Children with Chronic Renal Disease
  164. Chemotherapy with cytosine arabinoside in a child with Burkitt's lymphoma on maintenance hemodialysis and hemofiltration
  165. Acquired cystic kidney disease before and after renal transplantation
  166. Lipid levels in monocytes of patients with moderate hyperlipoproteinemia
  167. Lipoproteins in Children Treated with Continuous Peritoneal Dialysis
  168. ?Sterile peritonitis? caused by varicella in a child on maintenance peritoneal dialysis treatment
  169. Excessive urinary oxalate excretion after combined renal and hepatic transplantation for correction of hyperoxaluria type 1
  170. 136 LIPID LEVELS IN PLASMA AND MONOCYTES (MO) IN CHILDREN WITH END-STAGE RENAL DISEASE (ESRD)
  171. Serum interleukin-2 levels in a patient with focal segmental glomerulosclerosis
  172. A new percutaneous renal biopsy device for pediatric patients
  173. Lipoprotein profiles at different stages of the nephrotic syndrome
  174. Treatment of severe hypercalcemia with peritoneal dialysis in an infant with end-stage renal disease
  175. Hyperlipidemia in pediatric patients undergoing peritoneal dialysis
  176. Generalized amyloidosis secondary to xanthogranulomatous pyelonephritis
  177. ?Partial trisomy 22 and 11? due to a paternal 11;22 translocation associated with hirschsprung disease
  178. The Significance of Focal Global Sclerosis in Idiopathic Nephrotic Syndrome.
  179. Lipoprotein Profiles in Plasma and Dialysate of Children on CAPD
  180. Hemofiltration in Childhood
  181. Taurolidine-citrate vs heparin as catheter lock solutions in paediatric patients
  182. Prospective, multicenter, double-blind, randomized, cross-over study to evaluate efficacy and safety of sevelamer in the treatment of dyslipidemia in children with persisting proteinuria